The Effect of Dilution and Prolonged Injection Time on Dexamethasone-induced Perineal Irritation
The Effect of Dilution With Glucose and Prolonged Injection Time on Dexamethasone-induced Perineal Irritation
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Hanxiang Ma
- Phone Number: +86-13519591508
- Email: mahanxiang@hotmail.com
Study Contact Backup
- Name: Yonghai Zhang
- Phone Number: +86-15909508072
- Email: zhangyonghai826@aliyun.com
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged 18-65 years
- ASA physical status I-II
Exclusion Criteria:
- On regular use of analgesic
- Contraindication or allergy to steroid or glucose
- Drug or alcohol abuse
- Diagnosed with paresthesia or mental diseases
- Communication disorders
- Pregnancy or nursing
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: 2 ml dexamethasone (5 mg/ml)
50 patients receive 2 ml dexamethasone (5 mg/ml) , the injection time of dexamethasone was less than 2s.
|
receive 2ml dexamethasone (5mg/ml)
|
|
Experimental: 5 ml dexamethasone (2mg/ml)
50 patients receive 5 ml dexamethasone (2mg/ml) diluted with 5% glucose, the injection time of dexamethasone was 30s.
|
receive 5ml dexamethasone (2mg/ml) diluted with 5% glucose
|
|
Experimental: 10 ml dexamethasone (1mg/ml)
50 patients receive 10 ml dexamethasone (1mg/ml) diluted with 5% glucose, the injection time of dexamethasone was 30s.
|
receive 10ml dexamethasone (1mg/ml) diluted with 5% glucose
|
|
Experimental: 20 ml dexamethasone (0.5mg/ml)
50 patients receive 20 ml dexamethasone (0.5mg/ml) diluted with 5% glucose, the injection time of dexamethasone was 30s.
|
receive 20ml dexamethasone (0.5mg/ml) diluted with 5% glucose
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The incidence of dexamethasone-induced perineal irritation
Time Frame: During the first 3 min period after the injection of dexamethasone
|
The investigators record the number of cases of dexamethasone-induced perineal irritation (pain or pruritus) and calculate the incidence
|
During the first 3 min period after the injection of dexamethasone
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of perineal irritation
Time Frame: After the injection of dexamethasone, up to 5 minutes
|
If perineal irritation occurs, the investigators will record its duration
|
After the injection of dexamethasone, up to 5 minutes
|
|
The severity of perineal irritation
Time Frame: After the injection of dexamethasone, up to 5 minutes
|
If perineal irritation occurs, the investigators will assess its severity by using Visual Analogue Scale (the minimum is 0 and the maximum is 10, and the higher scores mean a worse outcome)
|
After the injection of dexamethasone, up to 5 minutes
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Yonghai Zhang, General Hospital of Ningxia Medical University
Study record dates
Study Major Dates
Study Start (Anticipated)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Anti-Inflammatory Agents
- Antineoplastic Agents
- Antiemetics
- Gastrointestinal Agents
- Glucocorticoids
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Antineoplastic Agents, Hormonal
- Protease Inhibitors
- Dexamethasone
- Dexamethasone acetate
- BB 1101
Other Study ID Numbers
Other Study ID Numbers
- Zhangyonghai02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.